You summarize the clinical risk without spreading identifiers:
Patient has a documented allergy (from EMR)
Current requested substitution may cross-react
Stock is limited
You propose a safe workflow: verify in EMR, confirm with prescriber, pharmacist suggests alternative, nurse acknowledges administration plan (closed-loop).
Pharmacist says:
“I can propose alternative A or B. Need confirmation from prescriber.”
Junior doctor is offline. Nurse pushes:
“Pasien marah, keluarga nunggu. Tolong cepat.”